NCS Multistage Holdings, Inc. Announces Fourth Quarter and Full Year 2019 Results
Fourth Quarter Results
- Total revenues of
$52.1 million , a 4% year-over-year increase - Net loss of
$(2.2) million and loss per diluted share of$(0.05) - Adjusted EBITDA of
$8.3 million and a 16% Adjusted EBITDA margin $11.2 million in cash on hand and$12.9 million of total debt as ofDecember 31, 2019
Financial Review
Fourth Quarter 2019 Financial Results
Revenues were
Gross profit, which we define as total revenues less total cost of sales exclusive of depreciation and amortization, was
Selling, general and administrative (“SG&A”) expenses of
Net loss was
Adjusted EBITDA was
Full Year 2019 Financial Results
For the year ended
Cash flows from operating activities during 2019 of
Capital Expenditures and Liquidity
The Company incurred capital expenditures of
As of
Review and Outlook
NCS’s Chief Executive Officer, Robert Nipper, commented, “NCS had a very successful year in 2019, despite a challenging market environment. Our revenue outperformed the underlying rig count in each of the
As market conditions deteriorated, we demonstrated our focus on controlling our expenses and maximizing our cash flow. We reduced our workforce by 6% in July and continue to increase the efficiency of our operations. During the year we continued to review our capital expenditure needs, leading to a year-over-year reduction of over
We currently expect that customer capital budgets in the
We believe that our products and services enable our customers to increase operating efficiencies, better understand and optimize their assets and reduce their costs, which has allowed us to improve our market position over time. We are delivering the breadth of our product and service offerings across the geographies where we operate and expect to continue to bring new technologies to our customers. We believe that we are well positioned to outperform the underlying customer spending changes that we expect in each of the
We will continue to be disciplined in making investments in our business. We expect our capital spending in 2020 to be at or below 2019 levels and we believe we are positioned to grow our free cash flow generation in 2020, which will further enhance our strong balance sheet and allow us to improve our return on invested capital.
I’d like to thank all of the employees at NCS and at Repeat Precision for their dedication and contributions. We have the right team and the right strategies in place to deliver value to customers, drive innovation in the industry and create value for our shareholders.”
Adjusted EBITDA, Adjusted EBITDA margin, Adjusted EBITDA Less Share-Based Compensation, Adjusted Net (Loss) Income, Adjusted Net (Loss) Earnings per Diluted Share and Free Cash Flow are non-GAAP financial measures. For an explanation of these measures and a reconciliation, refer to “Non-GAAP Financial Measures” below.
Conference Call
The Company will host a conference call to discuss its fourth quarter and full year 2019 results on
An audio replay of the conference call will be available shortly after the conclusion of the call and will remain available for approximately seven days. It can be accessed by dialing (855) 859-2056 within
About
Forward Looking Statements
This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as “anticipates,” “intends,” “plans,” “seeks,” “believes,” “estimates,” “expects” and similar references to future periods, or by the inclusion of forecasts or projections. Examples of forward-looking statements include, but are not limited to, statements we make regarding the outlook for our future business and financial performance. Forward-looking statements are based on our current expectations and assumptions regarding our business, the economy and other future conditions. Because forward-looking statements relate to the future, by their nature, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. As a result, our actual results may differ materially from those contemplated by the forward-looking statements. Important factors that could cause our actual results to differ materially from those in the forward-looking statements include regional, national or global political, economic, business, competitive, market and regulatory conditions and the following: declines in the level of oil and natural gas exploration and production activity within
Contact
Chief Financial Officer
(281) 453-2222
IR@ncsmultistage.com
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)
Three Months Ended | Year Ended | |||||||||||||||
2019 | 2018 | 2019 | 2018 | |||||||||||||
(Unaudited) | (Unaudited) | (Unaudited) | ||||||||||||||
Revenues | ||||||||||||||||
Product sales | $ | 34,893 | $ | 34,267 | $ | 145,826 | $ | 156,781 | ||||||||
Services | 17,201 | 15,921 | 59,659 | 70,182 | ||||||||||||
Total revenues | 52,094 | 50,188 | 205,485 | 226,963 | ||||||||||||
Cost of sales | ||||||||||||||||
Cost of product sales, exclusive of depreciation and amortization expense shown below |
18,049 | 17,292 | 75,081 | 74,892 | ||||||||||||
Cost of services, exclusive of depreciation and amortization expense shown below |
7,928 | 8,693 | 32,949 | 33,414 | ||||||||||||
Total cost of sales, exclusive of depreciation and amortization expense shown below |
25,977 | 25,985 | 108,030 | 108,306 | ||||||||||||
Selling, general and administrative expenses | 22,194 | 20,305 | 88,554 | 82,813 | ||||||||||||
Depreciation | 1,495 | 1,318 | 5,877 | 4,747 | ||||||||||||
Amortization | 1,108 | 3,231 | 4,559 | 13,090 | ||||||||||||
Change in fair value of contingent consideration | — | 133 | 37 | (2,872 | ) | |||||||||||
Impairments | — | 227,543 | 7,919 | 227,543 | ||||||||||||
Income (loss) from operations | 1,320 | (228,327 | ) | (9,491 | ) | (206,664 | ) | |||||||||
Other income (expense) | ||||||||||||||||
Interest expense, net | (428 | ) | (581 | ) | (1,925 | ) | (1,963 | ) | ||||||||
Other (expense) income, net | (41 | ) | 114 | 308 | 182 | |||||||||||
Foreign currency exchange (loss) gain | (280 | ) | 561 | (958 | ) | 162 | ||||||||||
Total other (expense) income | (749 | ) | 94 | (2,575 | ) | (1,619 | ) | |||||||||
Income (loss) before income tax | 571 | (228,233 | ) | (12,066 | ) | (208,283 | ) | |||||||||
Income tax expense (benefit) | 552 | (26,189 | ) | 10,752 | (23,052 | ) | ||||||||||
Net income (loss) | 19 | (202,044 | ) | (22,818 | ) | (185,231 | ) | |||||||||
Net income attributable to non-controlling interest | 2,196 | 1,521 | 10,005 | 5,086 | ||||||||||||
Net loss attributable to NCS Multistage Holdings, Inc. |
$ | (2,177 | ) | $ | (203,565 | ) | $ | (32,823 | ) | $ | (190,317 | ) | ||||
Loss per common share | ||||||||||||||||
Basic loss per common share attributable to NCS Multistage Holdings, Inc. |
$ | (0.05 | ) | (4.51 | ) | $ | (0.70 | ) | $ | (4.25 | ) | |||||
Diluted loss per common share attributable to NCS Multistage Holdings, Inc. |
$ | (0.05 | ) | (4.51 | ) | $ | (0.70 | ) | $ | (4.25 | ) | |||||
Weighted average common shares outstanding | ||||||||||||||||
Basic | 46,911 | 45,088 | 46,643 | 44,788 | ||||||||||||
Diluted | 46,911 | 45,088 | 46,643 | 44,788 | ||||||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except share data)
2019 | 2018 | |||||||
(Unaudited) | ||||||||
Assets | ||||||||
Current assets | ||||||||
Cash and cash equivalents | $ | 11,243 | $ | 25,131 | ||||
Accounts receivable—trade, net | 41,960 | 49,984 | ||||||
Inventories, net | 39,921 | 32,753 | ||||||
Prepaid expenses and other current assets | 2,444 | 2,037 | ||||||
Other current receivables | 5,028 | 4,685 | ||||||
Total current assets | 100,596 | 114,590 | ||||||
Noncurrent assets | ||||||||
Property and equipment, net | 32,974 | 32,296 | ||||||
15,222 | 23,112 | |||||||
Identifiable intangibles, net | 45,248 | 48,985 | ||||||
Deposits and other assets | 8,531 | 1,392 | ||||||
Deferred income taxes, net | 6 | 9,326 | ||||||
Total noncurrent assets | 101,981 | 115,111 | ||||||
Total assets | $ | 202,577 | $ | 229,701 | ||||
Liabilities and Stockholders’ Equity | ||||||||
Current liabilities | ||||||||
Accounts payable—trade | $ | 8,549 | $ | 7,167 | ||||
Accrued expenses | 3,451 | 4,084 | ||||||
Income taxes payable | 1,883 | 184 | ||||||
Current contingent consideration | — | 9,963 | ||||||
Current maturities of long-term debt | 1,481 | 2,236 | ||||||
Other current liabilities | 4,416 | 1,991 | ||||||
Total current liabilities | 19,780 | 25,625 | ||||||
Noncurrent liabilities | ||||||||
Long-term debt, less current maturities | 11,436 | 23,455 | ||||||
Other long-term liabilities | 4,860 | 1,258 | ||||||
Deferred income taxes, net | 2,956 | 3,132 | ||||||
Total noncurrent liabilities | 19,252 | 27,845 | ||||||
Total liabilities | 39,032 | 53,470 | ||||||
Commitments and contingencies | ||||||||
Stockholders’ equity | ||||||||
Preferred stock, |
— | — | ||||||
Common stock, |
||||||||
and 46,813,117 shares outstanding at |
||||||||
and 45,072,463 shares outstanding at |
469 | 451 | ||||||
Additional paid-in capital | 424,633 | 411,423 | ||||||
Accumulated other comprehensive loss | (80,811 | ) | (84,030 | ) | ||||
Retained deficit | (199,029 | ) | (166,206 | ) | ||||
at |
(652 | ) | (337 | ) | ||||
Total stockholders’ equity | 144,610 | 161,301 | ||||||
Non-controlling interest | 18,935 | 14,930 | ||||||
Total equity | 163,545 | 176,231 | ||||||
Total liabilities and stockholders' equity | $ | 202,577 | $ | 229,701 | ||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
Year Ended |
||||||||
2019 | 2018 | |||||||
(Unaudited) | ||||||||
Cash flows from operating activities | ||||||||
Net loss | $ | (22,818 | ) | $ | (185,231 | ) | ||
Adjustments to reconcile net loss to net cash provided by operating activities: |
||||||||
Depreciation and amortization | 10,436 | 17,837 | ||||||
Impairments | 7,919 | 227,543 | ||||||
Amortization of deferred loan cost | 312 | 334 | ||||||
Share-based compensation | 12,542 | 10,930 | ||||||
Provision for inventory obsolescence | 895 | 1,673 | ||||||
Deferred income tax expense (benefit) | 9,000 | (28,840 | ) | |||||
(Gain) loss on sale of property and equipment | (312 | ) | 74 | |||||
Change in fair value of contingent consideration | 37 | (2,872 | ) | |||||
Provision for doubtful accounts | 3,500 | 304 | ||||||
Payment of contingent consideration | (3,042 | ) | — | |||||
Changes in operating assets and liabilities: | ||||||||
Accounts receivable—trade | 4,735 | (4,213 | ) | |||||
Inventories, net | (7,639 | ) | (2,949 | ) | ||||
Prepaid expenses and other assets | 488 | (624 | ) | |||||
Accounts payable—trade | 2,580 | 219 | ||||||
Accrued expenses | (681 | ) | (2,430 | ) | ||||
Other liabilities | (1,606 | ) | (620 | ) | ||||
Income taxes receivable/payable | 1,603 | (17,109 | ) | |||||
Net cash provided by operating activities | 17,949 | 14,026 | ||||||
Cash flows from investing activities | ||||||||
Purchases of property and equipment | (6,123 | ) | (11,134 | ) | ||||
Purchase and development of software and technology | (251 | ) | (4,675 | ) | ||||
Proceeds from sales of property and equipment | 1,372 | 399 | ||||||
Net cash used by investing activities | (5,002 | ) | (15,410 | ) | ||||
Cash flows from financing activities | ||||||||
Equipment note borrowings | 835 | 1,988 | ||||||
Payments on equipment note and finance leases | (5,021 | ) | (2,422 | ) | ||||
Promissory note borrowings | — | 5,360 | ||||||
Payments on promissory note | — | (8,673 | ) | |||||
Payments on revolver | (10,000 | ) | — | |||||
Payment of contingent consideration | (6,958 | ) | — | |||||
Payment of deferred loan cost related to senior secured revolving credit facility | (871 | ) | — | |||||
Proceeds from the exercise of options for common stock, net | — | 1,079 | ||||||
(315 | ) | (162 | ) | |||||
Distribution to non-controlling interest | (6,000 | ) | (2,300 | ) | ||||
Proceeds from the issuance of ESPP shares | 1,025 | — | ||||||
Net cash used by financing activities | (27,305 | ) | (5,130 | ) | ||||
Effect of exchange rate changes on cash and cash equivalents | 470 | (2,164 | ) | |||||
Net change in cash and cash equivalents | (13,888 | ) | (8,678 | ) | ||||
Cash and cash equivalents beginning of period | 25,131 | 33,809 | ||||||
Cash and cash equivalents end of period | $ | 11,243 | $ | 25,131 | ||||
Supplemental cash flow information | ||||||||
Cash paid for interest, net of amounts capitalized | $ | 1,070 | $ | 1,373 | ||||
Cash paid for income taxes (net of refunds) | $ | 122 | $ | 22,356 | ||||
Noncash investing and financing activities | ||||||||
Assets obtained by entering into finance leases | $ | 1,383 | $ | 2,603 | ||||
Changes in accounts payable related to capital expenditures | $ | (599 | ) | $ | 783 |
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL INFORMATION
(In thousands, except per share data)
(Unaudited)
Non-GAAP Financial Measures
EBITDA is defined as net (loss) income before interest expense, net, income tax expense and depreciation and amortization. Adjusted EBITDA is defined as EBITDA adjusted to exclude certain items which we believe are not reflective of ongoing operating performance or which, in the case of an impairment and share-based compensation, are non-cash in nature. Adjusted EBITDA margin represents Adjusted EBITDA as a percentage of total revenues. Adjusted EBITDA Less Share-Based Compensation is defined as Adjusted EBITDA minus share-based compensation expense. Adjusted Net (Loss) Income is defined as net (loss) income attributable to
EBITDA, Adjusted EBITDA, Adjusted EBITDA margin, Adjusted EBITDA Less Share-Based Compensation, Adjusted Net (Loss) Income, Adjusted Net (Loss) Earnings per Diluted Share and Free Cash Flow (our “non-GAAP financial measures”) are not defined under generally accepted accounting principles (“GAAP”), are not measures of net income, income from operations, cash provided by operating activities or any other performance measure derived in accordance with GAAP, and are subject to important limitations. Our non-GAAP financial measures may not be comparable to similarly titled measures of other companies in our industry and are not measures of performance calculated in accordance with GAAP. Our non-GAAP financial measures have important limitations as analytical tools and you should not consider them in isolation or as substitutes for analysis of our financial performance as reported under GAAP and they should not be considered as alternatives to net income (loss), cash provided by operating activities or any other performance measures derived in accordance with GAAP as measures of operating performance or as alternatives to cash flow from operating activities as measures of our liquidity.
The tables below set forth reconciliations of our non-GAAP financial measures to the most directly comparable measure of financial performance calculated under GAAP:
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL INFORMATION
(In thousands, except per share data)
(Unaudited)
ADJUSTED NET (LOSS) INCOME AND ADJUSTED NET (LOSS) EARNINGS PER DILUTED SHARE
Three Months Ended | Year Ended | |||||||||||||||||||||||||||||||
Effect on Net Loss |
Impact on Diluted Loss Per Share |
Effect on Net Loss |
Impact on Diluted Loss Per Share |
Effect on Net Loss |
Impact on Diluted Loss Per Share |
Effect on Net Loss |
Impact on Diluted Loss Per Share |
|||||||||||||||||||||||||
Net loss attributable to |
$ | (2,177 | ) | $ | (0.05 | ) | $ | (203,565 | ) | $ | (4.51 | ) | $ | (32,823 | ) | $ | (0.70 | ) | $ | (190,317 | ) | $ | (4.25 | ) | ||||||||
Adjustments | ||||||||||||||||||||||||||||||||
Impairments (a) | — | — | 227,543 | 5.04 | 7,919 | 0.17 | 227,543 | 5.08 | ||||||||||||||||||||||||
Realized and unrealized (gains) losses (b) | 327 | 0.01 | (540 | ) | (0.01 | ) | 994 | 0.02 | (172 | ) | (0.01 | ) | ||||||||||||||||||||
Change in fair value of contingent consideration (c) | — | — | 133 | — | 37 | — | (2,872 | ) | (0.06 | ) | ||||||||||||||||||||||
Income tax impact from adjustments (d) | (118 | ) | — | (26,063 | ) | (0.58 | ) | 12,836 | 0.27 | (24,847 | ) | (0.56 | ) | |||||||||||||||||||
Adjusted net (loss) income attributable to |
$ | (1,968 | ) | $ | (0.04 | ) | $ | (2,492 | ) | $ | (0.06 | ) | $ | (11,037 | ) | $ | (0.24 | ) | $ | 9,335 | $ | 0.20 | ||||||||||
_____________________
(a) Represents non-cash impairment charges for goodwill during 2019 and goodwill and intangible assets during 2018 as the fair values were lower than the carrying values.
(b) Represents realized and unrealized foreign currency translation gains and losses primarily due to movement in the foreign currency exchange rates between the periods.
(c) The change in 2019 represents the difference between the
(d) Represents the income tax adjustments including the valuation allowance recorded to reduce the carrying value of our
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL INFORMATION
(In thousands)
(Unaudited)
ADJUSTED EBITDA, ADJUSTED EBITDA MARGIN, AND ADJUSTED EBITDA LESS SHARE-BASED COMPENSATION
Three Months Ended | Year Ended | |||||||||||||||
2019 | 2018 | 2019 | 2018 | |||||||||||||
Net income (loss) | $ | 19 | $ | (202,044 | ) | $ | (22,818 | ) | $ | (185,231 | ) | |||||
Income tax expense (benefit) | 552 | (26,189 | ) | 10,752 | (23,052 | ) | ||||||||||
Interest expense, net | 428 | 581 | 1,925 | 1,963 | ||||||||||||
Depreciation | 1,495 | 1,318 | 5,877 | 4,747 | ||||||||||||
Amortization | 1,108 | 3,231 | 4,559 | 13,090 | ||||||||||||
EBITDA | 3,602 | (223,103 | ) | 295 | (188,483 | ) | ||||||||||
Impairments (a) | — | 227,543 | 7,919 | 227,543 | ||||||||||||
Share-based compensation (b) | 3,050 | 2,733 | 12,204 | 10,930 | ||||||||||||
Professional fees (c) | 1,212 | 294 | 4,952 | 1,542 | ||||||||||||
Unrealized foreign currency loss (gain) (d) | 1,374 | (693 | ) | 1,691 | 1,479 | |||||||||||
Realized foreign currency (gain) loss (e) | (1,094 | ) | 132 | (733 | ) | (1,641 | ) | |||||||||
Change in fair value of contingent consideration (f) | — | 133 | 37 | (2,872 | ) | |||||||||||
Severance and other termination benefits (g) | — | — | 721 | — | ||||||||||||
Other (h) | 175 | 713 | 1,098 | 1,241 | ||||||||||||
Adjusted EBITDA | $ | 8,319 | $ | 7,752 | $ | 28,184 | $ | 49,739 | ||||||||
Adjusted EBITDA Margin | 16% | 15% | 14% | 22% | ||||||||||||
Adjusted EBITDA Less Share-Based Compensation | $ | 5,269 | $ | 5,019 | $ | 15,980 | $ | 38,809 | ||||||||
_____________________
(a) Represents non-cash impairment charges for goodwill during 2019 and goodwill and intangible assets during 2018 as the fair values were lower than the carrying values.
(b) Represents non-cash compensation charges related to share-based compensation granted to our officers, employees and directors.
(c) Represents non-capitalizable costs of professional services incurred in connection with our financings, legal proceedings and the evaluation of potential acquisitions.
(d) Represents unrealized foreign currency translation gains and losses primarily due to movement in the foreign currency exchange rates between the periods.
(e) Represents realized foreign currency translation gains and losses due to movement in the foreign currency exchange rates between the periods.
(f) The change in 2019 represents the difference between the
(g) Reflects charges incurred in connection with a reduction in workforce implemented in the third quarter of 2019.
(h) Represents the impact of a research and development subsidy that is included in income tax expense (benefit) in accordance with GAAP along with other charges and credits.
REVENUES BY GEOGRAPHIC AREA
(In thousands)
(Unaudited)
Three Months Ended | Year Ended | |||||||||||
2019 | 2018 | 2019 | 2018 | |||||||||
Product sales | $ | 16,856 | $ | 19,447 | $ | 79,128 | $ | 67,458 | ||||
Services | 5,793 | 8,008 | 24,163 | 35,984 | ||||||||
Total |
22,649 | 27,455 | 103,291 | 103,442 | ||||||||
Product sales | 15,942 | 13,218 | 59,895 | 80,871 | ||||||||
Services | 7,998 | 6,040 | 26,668 | 28,607 | ||||||||
Total |
23,940 | 19,258 | 86,563 | 109,478 | ||||||||
Other Countries | ||||||||||||
Product sales | 2,095 | 1,602 | 6,803 | 8,452 | ||||||||
Services | 3,410 | 1,873 | 8,828 | 5,591 | ||||||||
Total Other Countries | 5,505 | 3,475 | 15,631 | 14,043 | ||||||||
Total | ||||||||||||
Product sales | 34,893 | 34,267 | 145,826 | 156,781 | ||||||||
Services | 17,201 | 15,921 | 59,659 | 70,182 | ||||||||
Total revenues | $ | 52,094 | $ | 50,188 | $ | 205,485 | $ | 226,963 | ||||
Source: NCS Multistage Holdings, Inc.